Inhibrx Biosciences Insider Bought Shares Worth $998,784, According to a Recent SEC Filing

MT newswire2026/09/28 21:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:52 PM EDT, 09/28/2026 (MT Newswires) -- Mark Lappe, Director, Chief Executive Officer, on September 25, 2026, executed a purchase for 10,000 shares in Inhibrx Biosciences (INBX) for $998,784. Following the Form 4 filing with the SEC, Lappe has control over a total of 960,413 common shares of the company, with 960,413 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007919/000136607426000004/xslF345X05/wk-form4_1790632047.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Inhibrx Biosciences Insider Bought Shares Worth $998,784, According to a Recent SEC Filing

You may also like

Crypto prices